PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,983,914 | -4.3% | 2,132,867 | 0.0% | 13.93% | -60.1% |
Q2 2023 | $38,647,550 | -31.9% | 2,132,867 | 0.0% | 34.92% | -13.9% |
Q1 2023 | $56,734,262 | +37.6% | 2,132,867 | 0.0% | 40.55% | +131.3% |
Q4 2022 | $41,228,319 | -7.5% | 2,132,867 | 0.0% | 17.53% | -32.7% |
Q3 2022 | $44,556,000 | +160.8% | 2,132,867 | 0.0% | 26.04% | +131.8% |
Q2 2022 | $17,084,000 | +14.3% | 2,132,867 | 0.0% | 11.23% | +105.1% |
Q1 2022 | $14,951,000 | -48.1% | 2,132,867 | 0.0% | 5.48% | -33.9% |
Q4 2021 | $28,794,000 | -20.0% | 2,132,867 | 0.0% | 8.28% | +1.4% |
Q3 2021 | $36,003,000 | -42.0% | 2,132,867 | 0.0% | 8.17% | -72.4% |
Q2 2021 | $62,109,000 | -26.0% | 2,132,867 | 0.0% | 29.57% | -4.3% |
Q1 2021 | $83,886,000 | +73.1% | 2,132,867 | 0.0% | 30.90% | +98.8% |
Q4 2020 | $48,459,000 | +0.3% | 2,132,867 | 0.0% | 15.54% | -6.5% |
Q3 2020 | $48,309,000 | -30.2% | 2,132,867 | 0.0% | 16.63% | -47.9% |
Q2 2020 | $69,233,000 | – | 2,132,867 | – | 31.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |